New Times,
New Thinking.

  1. Politics
25 November 2009

Ed Miliband and Jenni Russell

What Jenni Russell doesn't tell you in her column on the Miliband brothers

By George Eaton

Our good friend Jenni Russell has a column in today’s Guardian dismissing the recent rise in David Miliband’s fortunes and attacking “a kind of arrogance” in his speeches.

The Foreign Secretary is usually seen as one of the more cerebral members of cabinet, but for Russell there is “no sign that he is thinking deeply about politics”.

Not content with this, she goes on to deliver an encomium to Ed Miliband, contrasting the “passionate, funny, self-deprecating” Ed with “remote, self-satisfied” David.

I take no issue with Russell’s praise for Ed. Watching him in action on the conference fringe this year, quoting Marx on the cyclical crises of capitalism, one saw a figure unusually at ease with Labour’s history and traditions. My colleague James correctly identified him as the “up-and-coming politician of 2009” in his predictions last year.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

But what’s missing from Russell’s column is a declaration of interest: Ed Miliband is the godfather of her child.

Sign up to the New Statesman newsletter and receive weekly updates from the team

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines